{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:20Z","timestamp":1787010140732,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) are considered important both in atherosclerosis and remodeling after acute myocardial infarction (AMI). We aimed to study genetic expression and presence of MMP-2, MMP-9, TIMP-1, TIMP-2 and the extracellular MMP-inducer (EMMPRIN) in coronary thrombi. Circulating levels and genetic expression in circulating leukocytes were also assessed, and relations to degree of myocardial injury measured by troponin T and time from symptom to PCI were explored. Expression of cell markers were also analyzed, indicating relations to cell types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Intracoronary thrombi were aspirated from 33 patients with ST-elevation myocardial infarction (STEMI). Blood samples with Pax-gene tubes were drawn at end of PCI and the next day. RNA was isolated from thrombi and leukocytes, and genes were relatively quantified by RT-PCR. Each thrombus was preserved for histology and immunohistochemistry analyzes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Genes coding for the five markers were present in 84\u2013100% of thrombi and immunohistochemically stained in 96\u2013100%. Expression of TIMP-1 in thrombi and in leukocytes correlated significantly to peak troponin T (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.393\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.026,\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.469\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.006, respectively). No significant correlations between genes expressed in thrombi and time from symptom to PCI were observed. TIMP-1 was connected mainly to monocytes\/macrophages in the thrombi.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MMP-2, MMP-9, TIMP-1, TIMP-2 and EMMPRIN were highly expressed in human coronary thrombi. The correlation between troponin T and the expression of TIMP-1 both in thrombi and in leukocytes at time of PCI indicates that TIMP-1 plays a role in myocardial damage early post-MI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001128","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T03:05:12Z","timestamp":1643684712000},"page":"446-455","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["TIMP-1 expression in coronary thrombi associate with myocardial injury in ST-elevation myocardial infarction patients"],"prefix":"10.1097","volume":"33","author":[{"given":"Jostein","family":"Nordeng","sequence":"first","affiliation":[{"name":"Center for Clinical Heart Research Oslo University Hospital Ullev\u00e5l"},{"name":"Department of Cardiology, Oslo University Hospital Ullev\u00e5l"},{"name":"Faculty of Medicine, University of Oslo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Schandiz","sequence":"additional","affiliation":[{"name":"Department of Pathology, Akershus University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein","family":"Solheim","sequence":"additional","affiliation":[{"name":"Center for Clinical Heart Research Oslo University Hospital Ullev\u00e5l"},{"name":"Department of Cardiology, Oslo University Hospital Ullev\u00e5l"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sissel","family":"\u00c5kra","sequence":"additional","affiliation":[{"name":"Center for Clinical Heart Research Oslo University Hospital Ullev\u00e5l"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Section for Interventional Cardiology, Department of Cardiology, Oslo University Hospital Ullev\u00e5l"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borghild","family":"Roald","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Oslo"},{"name":"Department of Pathology, Oslo University Hospital Ullev\u00e5l"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"Bendz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Oslo"},{"name":"Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Arnesen","sequence":"additional","affiliation":[{"name":"Center for Clinical Heart Research Oslo University Hospital Ullev\u00e5l"},{"name":"Faculty of Medicine, University of Oslo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnhild","family":"Helseth","sequence":"additional","affiliation":[{"name":"Center for Clinical Heart Research Oslo University Hospital Ullev\u00e5l"},{"name":"Department of Cardiology, Oslo University Hospital Ullev\u00e5l"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingebj\u00f8rg","family":"Seljeflot","sequence":"additional","affiliation":[{"name":"Center for Clinical Heart Research Oslo University Hospital Ullev\u00e5l"},{"name":"Department of Cardiology, Oslo University Hospital Ullev\u00e5l"},{"name":"Faculty of Medicine, University of Oslo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2017.09.007","article-title":"Metalloproteinases in atherosclerosis.","volume":"816","author":"Johnson","year":"2017","journal-title":"Eu J Pharmacol"},{"key":"R2-20250729","first-page":"57","article-title":"Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque.","volume":"15","author":"Chen","year":"2005","journal-title":"Int J Mol Med"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.amjcard.2005.08.020","article-title":"Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.","volume":"97","author":"Fukuda","year":"2006","journal-title":"Am J Cardiol"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI8768","article-title":"Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.","volume":"106","author":"Ducharme","year":"2000","journal-title":"J Clin Invest"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/eurheartj\/ehm003","article-title":"Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.","volume":"28","author":"Kelly","year":"2007","journal-title":"Eur Heart J"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.STR.0000196986.50059.e0","article-title":"Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms.","volume":"37","author":"Sluijter","year":"2006","journal-title":"Stroke"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.matbio.2015.03.005","article-title":"The role of TIMPs in regulation of extracellular matrix proteolysis.","volume":"44-46","author":"Arpino","year":"2015","journal-title":"Matrix Biol"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"3872367","DOI":"10.1155\/2020\/3872367","article-title":"The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability.","volume":"2020","author":"Li","year":"2020","journal-title":"Mediators of inflammation"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases.","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.amjcard.2010.03.060","article-title":"Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction.","volume":"106","author":"Kelly","year":"2010","journal-title":"Am J Cardiol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/eurheartj\/ehn315","article-title":"Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.","volume":"29","author":"Kelly","year":"2008","journal-title":"Eur Heart J"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000481684","article-title":"MMP-9 and Its regulators TIMP-1 and EMMPRIN in patients with acute ST-elevation myocardial infarction: a NORDISTEMI substudy.","volume":"139","author":"Opstad","year":"2018","journal-title":"Cardiology"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.106.613281","article-title":"Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis.","volume":"113","author":"Johnson","year":"2006","journal-title":"Circulation"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cvr\/cvv268","article-title":"Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte\/macrophage invasion.","volume":"109","author":"Di Gregoli","year":"2016","journal-title":"Cardiovasc Res"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCULATIONAHA.105.568162","article-title":"Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.","volume":"113","author":"Schmidt","year":"2006","journal-title":"Circulation"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.yexmp.2018.05.001","article-title":"The roles of CyPA and CD147 in cardiac remodelling.","volume":"104","author":"Su","year":"2018","journal-title":"Exp Mol Pathol"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0034-1390001","article-title":"CD147 in cardiovascular disease and thrombosis.","volume":"40","author":"Pennings","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"5525917","DOI":"10.1155\/2021\/5525917","article-title":"The inflammasome signaling pathway is actively regulated and related to myocardial damage in coronary thrombi from patients with STEMI.","volume":"2021","author":"Nordeng","year":"2021","journal-title":"Mediators Inflamm"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.carpath.2014.01.007","article-title":"Thrombus age, clinical presentation, and reperfusion grade in myocardial infarction.","volume":"23","author":"Carol","year":"2014","journal-title":"Cardiovasc Pathol"},{"key":"R22-20250729","first-page":"360","article-title":"Understanding interobserver agreement: the kappa statistic.","volume":"37","author":"Viera","year":"2005","journal-title":"Fam Med"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/CM9.0000000000001144","article-title":"Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy.","volume":"134","author":"Pang","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.critrevonc.2003.09.008","article-title":"TIMPs as multifacial proteins.","volume":"49","author":"Lambert","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"385901","DOI":"10.1155\/2014\/385901","article-title":"The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction.","volume":"2014","author":"Furenes","year":"2014","journal-title":"Mediators Inflamm"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.thromres.2014.11.028","article-title":"Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction.","volume":"135","author":"Helseth","year":"2015","journal-title":"Thromb Res"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI8768","article-title":"Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.","volume":"106","author":"Ducharme","year":"2000","journal-title":"J Clin Invest"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yjmcc.2016.10.005","article-title":"Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.","volume":"100","author":"Iyer","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/biom11040491","article-title":"Infarct in the Heart: what\u2019s MMP-9 Got to Do with It?","volume":"11","author":"Becirovic-Agic","year":"2021","journal-title":"Biomolecules"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4110\/in.2009.9.3.90","article-title":"The Stimulation of CD147 induces MMP-9 expression through ERK and NF-kappaB in macrophages: implication for atherosclerosis.","volume":"9","author":"Kim","year":"2009","journal-title":"Immune Netw"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12265-015-9608-6","article-title":"Function of CD147 in atherosclerosis and atherothrombosis.","volume":"8","author":"Wang","year":"2015","journal-title":"J Cardiovasc Transl Res"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIRCRESAHA.107.157990","article-title":"Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.","volume":"102","author":"Schmidt","year":"2008","journal-title":"Circ Res"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:04:19Z","timestamp":1753812259000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001128","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,31]]}}}